Nixon Peabody
Bank of America
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen braces for biosimilars rules

By   /   Friday, October 7th, 2011  /   Comments Off on Amgen braces for biosimilars rules

    Print       Email
The U.S. Food and Drug Administration is set to release guidelines for biosimilar drugs by year’s end. The shape of those guidelines will determine whether the new drugs are a competitive threat or a potential market opportunity for Amgen, the world’s largest biotechnology firm and the biggest private-sector employer in Ventura County. Biosimilars are the…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Mindbody’s Stollmeyer to be executive chair of the board

Read More →